Literature DB >> 28980003

Axonal Protection by Ripasudil, a Rho Kinase Inhibitor, via Modulating Autophagy in TNF-Induced Optic Nerve Degeneration.

Yasushi Kitaoka1,2, Kana Sase1, Chihiro Tsukahara1,2, Kaori Kojima1, Akira Shiono1, Jiro Kogo1, Naoto Tokuda1, Hitoshi Takagi1.   

Abstract

Purpose: The Rho kinase inhibitor ripasudil decreases intraocular pressure, although its role in optic nerve axonal damage should be clarified. We therefore investigated whether ripasudil modulates TNF-induced axonal loss and affects autophagy machinery after the induction of optic nerve degeneration.
Methods: Rats were given intravitreal injection of TNF, concomitant injection of ripasudil hydrochloride hydrate and TNF, or ripasudil alone. Axon numbers were counted to evaluate the effects of ripasudil against axon loss. Immunoblot analysis was performed to examine p62 as well as LC3-II expression in optic nerves. Electron microscopy was used to determine autophagosome numbers in axons and glia. Immunogold labeling was performed to evaluate autophagosomes in axons.
Results: Ripasudil injected intravitreally resulted in significant neuroprotection against TNF-induced axon loss. Intravitreal TNF injection upregulated p62 in the optic nerve, but ripasudil completely inhibited this increment. The ripasudil alone injection diminished p62 and enhanced LC3-II protein levels significantly compared with baseline. Ripasudil-induced upregulation of LC3-II was seen after TNF injection, and immunohistochemical analysis revealed that LC3 colocalized in nerve fibers. Electron microscopic analysis revealed that autophagosomes were present in axons and glia, although autophagosome numbers increased significantly after ripasudil injection only in axons. Conclusions: These results suggest that ripasudil-enhanced intra-axonal autophagy is at least partly involved in axonal protection.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28980003     DOI: 10.1167/iovs.17-22000

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  6 in total

Review 1.  Impact of the clinical use of ROCK inhibitor on the pathogenesis and treatment of glaucoma.

Authors:  Megumi Honjo; Hidenobu Tanihara
Journal:  Jpn J Ophthalmol       Date:  2018-02-14       Impact factor: 2.447

Review 2.  Neuro-protection and neuro-regeneration of the optic nerve: recent advances and future directions.

Authors:  Kimberly K Gokoffski; Micalla Peng; Basheer Alas; Phillip Lam
Journal:  Curr Opin Neurol       Date:  2020-02       Impact factor: 5.710

3.  Autophagy and post-ischemic conditioning in retinal ischemia.

Authors:  Biji Mathew; Mohansrinivas Chennakesavalu; Monica Sharma; Leianne A Torres; Clara R Stelman; Sophie Tran; Raj Patel; Nathan Burg; Maryna Salkovski; Konrad Kadzielawa; Figen Seiler; Leslie N Aldrich; Steven Roth
Journal:  Autophagy       Date:  2020-05-26       Impact factor: 16.016

4.  Tumor Necrosis Factor Inhibition in the Acute Management of Traumatic Optic Neuropathy.

Authors:  Brian C Tse; Galina Dvoriantchikova; Wensi Tao; Ryan A Gallo; John Y Lee; Steven Pappas; Roberta Brambilla; Dmitry Ivanov; David T Tse; Daniel Pelaez
Journal:  Invest Ophthalmol Vis Sci       Date:  2018-06-01       Impact factor: 4.799

5.  Axonal Protection by Netarsudil, a ROCK Inhibitor, Is Linked to an AMPK-Autophagy Pathway in TNF-Induced Optic Nerve Degeneration.

Authors:  Yasushi Kitaoka; Kana Sase; Chihiro Tsukahara; Naoki Fujita; Ibuki Arizono; Jiro Kogo; Naoto Tokuda; Hitoshi Takagi
Journal:  Invest Ophthalmol Vis Sci       Date:  2022-01-03       Impact factor: 4.799

Review 6.  The interplay of autophagy and oxidative stress in the pathogenesis and therapy of retinal degenerative diseases.

Authors:  Kun-Che Chang; Pei-Feng Liu; Chia-Hsuan Chang; Ying-Cheng Lin; Yen-Ju Chen; Chih-Wen Shu
Journal:  Cell Biosci       Date:  2022-01-03       Impact factor: 7.133

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.